Contents
DDW the quarterly business review of drug discovery & development
Publisher and Editor-in-Chief Robert Jordan
Robert@rjcoms.com
Consultant Editor Dr Roger Brimblecombe
Contributing Author Dr John Comley
Publishing Manager Damian Doherty
Damian@rjcoms.com
Design & Production Melissa Chadderton
melissa@rhubarbcreative.demon.co.uk
Circulation & Production Controller Charles Davenport
Charles@rjcoms.com
Editorial Advisors Dr Steve Arlington Dr Nigel Brown Dr David Clough Dr Gregory Lennon Dr Keith Mansford Dr Stephen Naylor Dr George Poste Dr Amber Salzman Dr David U’Prichard Dr Timothy Wells Dr Rene Ziegler
Drug Discovery World (USPS 018-892) is published four times a year by RJ Communications & Media Ltd, 39 Vineyard Path, London SW14 8ET, United Kingdom. Tel: +44 (0)20 8487 5656 Fax: +44 (0)20 8487 5666 E-mail:
Robert@rjcoms.com
Subscription Rates Annual Subscription (four Issues): £89 UK & Europe; $175 USA & Canada; £99 Rest of World
Airfreight and mailing in the USA by Agent Air Business, C/O Priority Airfreight NY Ltd, 147-29 182nd Street, Jamaica, NY11413. Periodical postage paid at Jamaica, NY 11413. US Postmaster: Send address changes to Drug Discovery World, C/O Air Business Ltd/Priority Airfreight NY Ltd, 147-29 182nd Street, Jamaica, NY 11413. Subscription records are maintained at RJ Communications & Media Ltd, 39 Vineyard Path, London SW14 8ET, UK. Air Business Ltd is acting as our mailing agent.
© 2011 RJ Communications & Media Ltd All rights reserved. ISSN 1469-4344
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the copyright holder. While the publishers believe that all information contained in this publication was correct at the time of going to press, they can accept no liability for any inaccuracies that may appear or loss suffered directly or indirectly by any reader as a result of any advertisement, editorial, photographs or other material published in Drug Discovery World.
dr ug discov er y wo r l d contents
VOLUME 12 ISSUE 2 ● SPRING 2011 Introduction
Dr Roger Brimblecombe Consultant Editor
Drug Development
The Benefits of Drug Repositioning Dr Aris Persidis
Drug Discovery
Enabling the Promise of Stem Cells Robert Shaw and Dr Jeff Till
Genomics
The Post Genomics Era – What Does It All Mean and How Can We Translate It? Dr Chris Torrance
Therapeutics
Regenerative Medicine – A Paradigm Shift in Healthcare Michael Werner, Morrie Ruffin and Elizabeth West
Epigenetics
Epigenetics – An Emerging Target Class for Drug Screening Dr John Comley
Molecular Diagnostics
The Future of Molecular Diagnostics for Cancer – A ‘Personalised’ Perspective Dr Cliff Murray
Cell Biology
3D Cell Culture – Developments in Technology to Improve in vitro Analyses Prof Stefan Pryziborski
Show Preview
European Laboratory Automation, Hamburg, Germany Biologics
Balancing a Biologics Pipeline – Why Biosuperiors Represent a Solid Counterbalance to an Innovative Research and Development Programme Dr Herren Wu
7 9
15 25 33 40 57
67 74 76
Front cover illustration courtesy of Victor Habbick Visions/Science Photo Library Drug Discovery World Spring 2011 5
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80